fbpx
Medical Innovation Exchange

Ever the optimist, Biogen secures FDA priority review for ALS drug that flunked phase 3

https://www.fiercebiotech.com/biotech/ever-optimists-biogen-secures-priority-review-als-drug-failed-phase-3

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.